Dec 8 (Reuters) - Indian drugmaker Dr Reddy's (REDY.NS), opens new tab signed an exclusive licensing pact with Australia's Immutep (IMM.AX), opens new tab to develop and distribute the latter's cancer ...
Dr. Reddy’s Laboratories is paying $20 million upfront for the rights to Immutep’s phase 3-stage LAG-3 candidate in certain territories while leaving the Australian biotech with ownership in key ...
India have played 10 One Day Internationals at this venue with mixed results, including a 10-wicket loss to Australia. South Africa has limited experience on this ground and will look to adapt quickly ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min BlueLinx CEO Shyam Reddy has ...
Indian filmmaker Raam Reddy is moving ahead with his third feature, “Lavender Fire”, a pared-down coming-of-age drama set in Mumbai’s modelling and influencer scene. The project follows Reddy’s Berlin ...
The leadership change was made by Digital Domain's board of directors and key investors and follows the exit of former president and COO Lala Gavgavian. By Winston Cho Sudhir Reddy has been named the ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min AAR's $78M acquisition of HAECO ...
President Trump wants pharmaceutical production to return to the United States. A shuttered factory in Louisiana shows how hard that will be for generic medicines. Dr. Reddy’s, an Indian generic ...
CADDO PARISH, La. — The victim of a fatal single-vehicle crash in west Caddo Parish on Sunday has been officially identified by the Caddo Parish Coroner's office. Marshall Reddy Jr., 27, of Shreveport ...
COLUMBIA — It took years for South Carolina legislators to broker a compromise to reform how the General Assembly picks state judges. Now, many of the same lawmakers who helped strike the deal last ...
Dr. Reddy’s Laboratories remains a compelling buy due to underappreciated growth in biosimilars and GLP-1 segments, despite near-term headwinds. RDY's Q2 FY26 results showed modest revenue growth, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback